Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-olsNicolas Lebouvier, Marc Le Borgne, Patrícia Recordon-Pinson et al.|Pharmaceuticals|2020Cited by 21
The Risk of Venous Thromboembolism Associated with the Factor V Leiden Mutation and Low B-Vitamin StatusRima Obeid, Wolfgang Herrmann, Tarek Hakki et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2003Cited by 11
Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-olsNicolas Lebouvier, Marc Le Borgne, Fabrice Pagniez et al.|Publications of the UdS (Saarland University)|2020Cited by 0